Globus Medical (NYSE:GMED) announced today that it agreed to acquire chronic pain treatment developer Nevro (NYSE:NVRO).
1 小时
The New Times on MSNEquity for all: Championing disability inclusion in healthcareOver time, disability has become a structural factor influencing the quality of life, access to opportunities and health outcomes of those who are affected. According to the World Health Organization ...
Two-year follow-up data from 34 subjects in the VenoValve pivotal trial show sustained clinical improvement and continued patient benefit, from 12 months to 24 months.
Bill Gates warns about the rapid advancements and implications of AI on sectors like education and healthcare, stressing the ...
Auxilium 3D prints medical devices onboard the ISS. The AMP-1 bioprinting system remains on the ISS to print implants.
Dr. KU Natarajan and Dr. Nachiket, took to the stage to explore the role of cutting-edge technology in the future of ...
Hill & Ioppolo Oral & Dental Implant Surgery of Lubbock hosted a career event Thursday, to help students looking to be future ...
The unique structure of PAMs has the potential to transform industries, from healthcare to robotics, by offering properties never before seen in materials science. PAMs represent a bold step forward ...
The strides we've made in this field inspire hope for a future where hearing loss is not a barrier but a challenge we can ...
Montgomery County's Globus Medical has agreed to acquire a California life sciences company focused on treating chronic pain ...
From AI-powered hardware to the reinvention of legacy products, here is what’s shaping the future of physical products.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果